These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8530596)

  • 21. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
    Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
    Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN).
    Luetters C; Huang MH; Seeman T; Buckwalter G; Meyer PM; Avis NE; Sternfeld B; Johnston JM; Greendale GA
    J Womens Health (Larchmt); 2007 Apr; 16(3):331-44. PubMed ID: 17439378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
    Sherman BM; West JH; Korenman SG
    J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.
    Randolph JF; Sowers M; Bondarenko IV; Harlow SD; Luborsky JL; Little RJ
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1555-61. PubMed ID: 15070912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum gonadotropin, sex steroid, and immunoreactive inhibin levels in the first two years of life.
    Burger HG; Yamada Y; Bangah ML; McCloud PI; Warne GL
    J Clin Endocrinol Metab; 1991 Mar; 72(3):682-6. PubMed ID: 1900069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Investigation of the change of adiponectin level with menopause status in middle aged women and its relationship with androgen].
    Wu Y; Zheng C; Chen D; Xie M
    Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):356-60. PubMed ID: 26311455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum follicle stimulating hormone and estradiol in peri/postmenopausal women attending Siriraj Menopause Clinic: a retrospective study.
    Angsuwathana S; Tanmahasamut P; Rattanachaiyanont M; Dangrat C; Techatrisak K; Indhavivadhana S; Leerasiri P
    J Med Assoc Thai; 2006 Aug; 89(8):1101-8. PubMed ID: 17048416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
    Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
    Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
    Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
    J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of the relationship between follicular stimulating hormone, deoxypyridinoline, estradiol, and inhibin as decision criterion for starting replacement hormone therapy in climacteric and its correlation with symptomatology].
    Carranza Lira S; Cortés Fuentes E; González Legorreta SL
    Ginecol Obstet Mex; 2000 Jun; 68():242-8. PubMed ID: 10939192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle.
    Hee JP; MacNaughton J; Bangah M; Zissimos M; McCloud PI; Healy DL; Burger HG
    J Clin Endocrinol Metab; 1993 May; 76(5):1340-3. PubMed ID: 8496327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disturbances of sleep continuity in women during the menopausal transition.
    Słopień R; Wichniak A; Pawlak M; Słopień A; Warenik-Szymankiewicz A; Sajdak S
    Psychiatr Pol; 2015; 49(3):615-23. PubMed ID: 26276926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN).
    Tepper PG; Randolph JF; McConnell DS; Crawford SL; El Khoudary SR; Joffe H; Gold EB; Zheng H; Bromberger JT; Sutton-Tyrrell K
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2872-80. PubMed ID: 22659249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexuality, hormones and the menopausal transition.
    Dennerstein L; Dudley EC; Hopper JL; Burger H
    Maturitas; 1997 Mar; 26(2):83-93. PubMed ID: 9089557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.